Pharmaceutical composition for treating haemorrhagic shock...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/36 (2006.01) A61P 7/04 (2006.01)

Patent

CA 2634026

The invention is concerned with the use of a peptide comprising the N-terminal sequence Gly-His-Arg-Pro-Leu-Asp-Lys-Lys-Arg-Glu-Glu-Ala-Pro-Ser-Leu-Arg-Pro-Ala-Pro--- Pro-Pro-Ile-Ser-Gly-Gly-Gly-Tyr-Arg or any allelic variant or derivative of said peptide possessing the biological property of matching the inducible VE-cadherin binding motif on the B.beta.-chain (i.e. B.beta.15-42) of human fibrin for the preparation of a pharmaceutical preparation for the treatment of shock, more specifically of hemorrhagic shock.

L'invention concerne l'utilisation d'un peptide comprenant une séquence à N terminaux Gly-His-Arg-Pro-Leu-Asp-Lys-Lys-Arg-Glu-Glu-Ala-Pro-Ser-Leu-Arg-Pro-Ala- Pro-Pro-Pro-Ile-Ser-Gly-Gly-Gly-Tyr-Arg, ou d'une variante ou d'un dérivé quelconque de ce peptide, possédant des propriétés biologiques, avec lequel des motifs de liaison de VE-cadhérine inductibles s'adaptent à la chaîne Bß (c'est-à-dire. Bß<SUB>15-42</SUB>) de la fibrine humaine, en vue de produire une composition pharmaceutique destinée à un traitement de choc, plus précisément au traitement d'un choc hémorragique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical composition for treating haemorrhagic shock... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for treating haemorrhagic shock..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for treating haemorrhagic shock... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1939345

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.